Billed as ‘Liberation Day’, President Donald Trump has pledged to unleash a new round of tariffs on April 2 that are likely ...
3d
Irish Examiner on MSNTrump's tariff threat on Irish pharma sector puts €44bn exports at 'considerable risk'Tariffs drive inflation, negatively impacting consumers on both sides of the Atlantic. Increased protectionism is in nobody’s ...
Impending U.S. tariffs could have a deep impact on the Irish economy and its strong reliance on pharmaceuticals and digital.
Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro ... At the time, obesity expert and physiologist Dr Simon Cork of Anglia Ruskin University ...
Eli Lilly and Company Ltd. Strattera Summary of ... practice lecturer at the School of Pharmacy, University College Cork, Ireland and her research interests are in the field of ...
2d
Irish Examiner on MSNEli Lilly fails to get European approval for Alzheimer's drug KisunlaLilly will seek review of decision which said drug's benefits don’t outweigh risk of potentially fatal bleeding in the brain ...
Eli Lilly has emerged as a popular growth stock thanks to its strength in the weight loss space. But the pharma giant also has an enormous opportunity in the Alzheimer's Disease market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results